HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniele Tomassoni Selected Research

Capsaicin (Zostrix)

5/2022Unveiling the Molecular Mechanisms Driving the Capsaicin-Induced Immunomodulatory Effects on PD-L1 Expression in Bladder and Renal Cancer Cell Lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniele Tomassoni Research Topics

Disease

13Hypertension (High Blood Pressure)
06/2021 - 01/2002
10Cognitive Dysfunction
01/2021 - 10/2002
9Obesity
03/2022 - 01/2017
6Gliosis
01/2021 - 05/2004
6Dementia (Dementias)
01/2015 - 10/2002
5Neoplasms (Cancer)
04/2022 - 12/2014
5Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
01/2012 - 10/2002
4Hypertrophy
04/2022 - 04/2003
4Body Weight (Weight, Body)
10/2021 - 01/2020
4Stroke (Strokes)
02/2013 - 11/2008
3Inflammation (Inflammations)
04/2021 - 01/2017
3Pain (Aches)
01/2021 - 04/2018
3Alzheimer Disease (Alzheimer's Disease)
01/2012 - 02/2006
3Cerebrovascular Disorders (Cerebrovascular Occlusion)
08/2009 - 11/2006
2Urinary Bladder Neoplasms (Bladder Cancer)
06/2022 - 12/2014
2Fibrosis (Cirrhosis)
06/2021 - 04/2003
2Glioblastoma (Glioblastoma Multiforme)
04/2019 - 07/2016
2Glioma (Gliomas)
04/2019 - 07/2016
2Ischemic Stroke
08/2009 - 11/2008
2Essential Hypertension
11/2007 - 11/2002
2Neurobehavioral Manifestations
06/2007 - 11/2006
2Necrosis
05/2004 - 04/2003
1Circulating Neoplastic Cells
06/2022
1Kidney Neoplasms (Kidney Cancer)
05/2022
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2022
1Wounds and Injuries (Trauma)
03/2022
1Nervous System Diseases (Neurological Disorders)
11/2021
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
06/2021
1Cardiovascular Diseases (Cardiovascular Disease)
04/2021
1Hyperlipidemias (Hyperlipidemia)
03/2021
1Neuroinflammatory Diseases
01/2021
1Low Back Pain (Lumbago)
01/2021
1Bulimia (Binge Eating)
11/2020
1Carcinogenesis
11/2020
1Breast Neoplasms (Breast Cancer)
11/2020
1Overweight
01/2019
1Hypersensitivity (Allergy)
04/2018
1Neuroblastoma
04/2018
1Thymoma (Thymic Carcinoma)
03/2018

Drug/Important Bio-Agent (IBA)

10Cholinergic Agents (Cholinergics)IBA
03/2022 - 10/2002
71,4-dihydropyridine (dihydropyridine)IBA
11/2008 - 01/2002
6Pharmaceutical PreparationsIBA
04/2022 - 11/2002
6Thioctic Acid (Lipoic Acid)IBA
06/2021 - 01/2013
6AntioxidantsIBA
06/2021 - 02/2013
5Messenger RNA (mRNA)IBA
06/2022 - 07/2016
5Proteins (Proteins, Gene)FDA Link
04/2022 - 05/2004
5Glycerylphosphorylcholine (Choline Alfoscerate)IBA
02/2013 - 10/2002
5Antihypertensive Agents (Antihypertensives)IBA
08/2009 - 11/2002
4Ion Channels (Ion Channel)IBA
04/2022 - 12/2014
4Glial Fibrillary Acidic ProteinIBA
01/2016 - 10/2002
4Choline (Choline Chloride)IBA
01/2015 - 06/2007
4Nicardipine (Dagan)FDA LinkGeneric
08/2009 - 10/2002
3Cytidine Diphosphate Choline (Citicoline)IBA
02/2013 - 10/2002
3Cholinesterase Inhibitors (Anticholinesterases)IBA
08/2009 - 02/2006
3lercanidipineIBA
06/2007 - 10/2002
2Nucleic AcidsIBA
06/2021 - 01/2016
2Reactive Oxygen Species (Oxygen Radicals)IBA
05/2021 - 04/2019
2Caspase 3 (Caspase-3)IBA
11/2020 - 07/2016
2Insulin (Novolin)FDA Link
05/2020 - 01/2020
2Triglycerides (Triacylglycerol)IBA
01/2020 - 01/2017
2CholesterolIBA
01/2020 - 01/2017
2Acetylcholine (Acetylcholine Chloride)FDA Link
01/2015 - 06/2007
2CalciumIBA
12/2014 - 06/2007
2Phospholipids (Phosphatides)FDA LinkGeneric
02/2013 - 06/2007
2Nimodipine (Modus)FDA LinkGeneric
11/2008 - 10/2002
2Phosphatidylcholines (Phosphatidylcholine)IBA
06/2007 - 11/2006
2Vasodilator Agents (Vasodilators)IBA
10/2002 - 01/2002
2Hydralazine (Apresoline)FDA LinkGeneric
10/2002 - 01/2002
1Capsaicin (Zostrix)FDA Link
05/2022
1CannabidiolIBA
04/2022
1Imatinib Mesylate (Gleevec)FDA Link
04/2022
1Oxidants (Oxidizing Agents)IBA
05/2021
1Interleukin-6 (Interleukin 6)IBA
04/2021
1LeptinIBA
04/2021
1CytokinesIBA
04/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2021
1FlavonoidsIBA
03/2021
1PhytochemicalsIBA
03/2021
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2021
1Vesicular Acetylcholine Transport Proteins (Vesicular Acetylcholine Transporter)IBA
01/2021
1MelanocortinsIBA
11/2020
1Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA
11/2020
1acetylshikoninIBA
11/2020
1NaphthoquinonesIBA
11/2020
1human ERBB2 proteinIBA
11/2020
1Superoxide DismutaseIBA
03/2020
1Carbonyl Cyanide m-Chlorophenyl Hydrazone (CCCP)IBA
04/2019
1SphingomyelinsIBA
04/2019
1mesoxalonitrileIBA
04/2019
1bafilomycin AIBA
04/2019
1Blood Glucose (Blood Sugar)IBA
01/2019
1Bortezomib (Velcade)FDA Link
04/2018
1Acetylcarnitine (Alcar)IBA
04/2018
1Gabapentin (Neurontin)FDA LinkGeneric
04/2018
1ParaffinIBA
03/2018
1CTLA-4 AntigenIBA
03/2018

Therapy/Procedure

2Ligation
01/2021 - 04/2018
2Therapeutics
12/2014 - 10/2002
2Drug Therapy (Chemotherapy)
12/2014 - 03/2011
1Oral Administration
10/2021